Exactech Innovations Presented at 2016 Orthopaedic Research Society Annual Meeting

Studies Include Reverse Shoulder Surgery, Hip and Knee Arthroplasty, and Impact of ExactechGPS® Computer Assisted Technology in Orthopaedic Surgery

GAINESVILLE, Fla. (March 3, 2016) – Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, will present more than 25 scientific posters and presentations regarding its latest product and instrumentation advancements, as well as the use of ExactechGPS® computer assisted technology in orthopaedic surgery during the 2016 Orthopaedic Research Society (ORS) annual meeting, March 5 – 8 in Orlando, Fla.

Research included cadaveric computer-controlled studies, clinical outcome studies and bench test studies with topics ranging from reverse shoulder surgery and hip and knee arthroplasty to the impact of computer assisted surgery and alternatives for cartilage repair.

“The wide-ranging scope and quality of these studies are a great example of the way Exactech employees embody our value of innovation and our commitment to improving patient outcomes with proven advancements,” said Exactech Co-founder and Executive Vice President of Research and Development Gary Miller, PhD. “It’s rewarding to see both basic scientific and clinical information that result from collaboration among our scientists, engineers and surgeon partners. I’m proud to see these teams recognized for the contributions they are making to our field.”

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech Inc. can be found at https://aigrenoble.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at https://aigrenoble.com andhttps://www.hawkassociates.com.

An investment profile on Exactech may be found at https://www.hawkassociates.com/profile/exac.cfm. To receive future releases in email alerts, sign up at https://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

Investor contacts
Jody Phillips
Executive Vice President of Finance & Chief Financial Officer

Julie Marshall or Frank Hawkins
Hawk Associates
Email: EXAC@hawkassociates.com

Media contact
Priscilla Bennett
Vice President, Corporate & Marketing Communication